Prudential Financial
BHVN

Prudential Financial’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Prudential Financial’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-4,511
Closed -$684K – 2767
2022
Q3 		$684K Sell
4,511
-895
-17% -$133K ﹤0.01% 1928
2022
Q2 		$788K Sell
5,406
-174
-3% -$22.2K ﹤0.01% 1915
2022
Q1 		$662K Buy
5,580
+1,122
+25% +$140K ﹤0.01% 2070
2021
Q4 		$660K Sell
4,458
-13,353
-75% -$1.7M ﹤0.01% 2093
2021
Q3 		$2.47M Buy
17,811
+13,315
+296% +$1.66M ﹤0.01% 1345
2021
Q2 		$437K Buy
4,496
+350
+8% +$28.4K ﹤0.01% 2179
2021
Q1 		$283K Buy
4,146
+77
+2% +$6.23K ﹤0.01% 2294
2020
Q4 		$349K Buy
4,069
+56
+1% +$4.75K ﹤0.01% 2201
2020
Q3 		$261K Buy
4,013
+879
+28% +$57.6K ﹤0.01% 2212
2020
Q2 		$229K Buy
+3,134
New +$167K ﹤0.01% 2207
2019
Q4 		– Sell
-24,188
Closed -$1.01M – 2539
2019
Q3 		$1.01M Sell
24,188
-59,029
-71% -$2.49M ﹤0.01% 1853
2019
Q2 		$3.65M Buy
+83,217
New +$4.69M 0.01% 1299

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return

Prudential Financial's BHVN Position: Q4 2022 in Review

Prudential Financial sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 4,511 shares — an estimated $684K sold.

Prudential Financial first reported a position in BHVN in Q2 2019 and held it in 12 quarters. The position peaked at $3.65M in Q2 2019. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • Prudential Financial reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • Prudential Financial sold 4,511 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $684K.
  • Prudential Financial first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q2 2019 and held it in 12 quarters.
  • Prudential Financial's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $3.65M in Q2 2019.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on Prudential Financial's 13F filing for Q4 2022, filed 14 Feb 2023.